P3 Health Partners (PIII) Gains from Sales and Divestitures (2019 - 2022)

P3 Health Partners (PIII) has reported Gains from Sales and Divestitures for 4 consecutive years, with $5.0 million the latest figure, recorded in Q4 2022.

• Gains from Sales and Divestitures for Q4 2022 came in at $5.0 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2022 was $5.0 million (changed N/A YoY), and the FY2022 annual result was $5.0 million, changed N/A from the prior year.
• Gains from Sales and Divestitures was $5.0 million for Q4 2022 at P3 Health Partners, up from $5.0 million in the prior quarter.
• Over five years, Gains from Sales and Divestitures peaked at $5.0 million in Q4 2022 and troughed at $443750.0 in Q4 2020.
• Average Gains from Sales and Divestitures over 4 years is $2.5 million, with a median of $660417.0 recorded in 2021.
• The widest YoY moves for Gains from Sales and Divestitures: up 29.93% in 2020, down 29.93% in 2020.
• Over 4 years, Gains from Sales and Divestitures stood at $633333.0 in 2019, then dropped by 29.93% to $443750.0 in 2020, then surged by 48.83% to $660417.0 in 2021, then soared by 662.85% to $5.0 million in 2022.
• Per Business Quant data, the three most recent Gains from Sales and Divestitures figures were $5.0 million in Q4 2022, $5.0 million in Q3 2022, and $4.9 million in Q2 2022.